September 22, 2025

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 13% Upside Potential in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN), a leader in the healthcare sector specializing in diagnostics and research, has captured investor attention with its potential upside of 13.04%, according to recent analyst ratings...

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Growth with a 2.29% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD), a stalwart in the Healthcare sector, specifically in Diagnostics & Research, presents an intriguing proposition for investors. With a market capitalization of $26.07 billion, this..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Tenet Healthcare Corporation (THC) Stock Analysis: Navigating Growth with a Strong 29.65% ROE

Tenet Healthcare Corporation (NYSE: THC), a prominent entity in the medical care facilities industry, holds a significant position in the U.S. healthcare sector. With a market capitalization of $16.8 billion,..

Smith & Nephew SNATS, Inc. (SNN) Valuation Insights: Healthcare Giant with a 1.57% Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, is carving a niche for itself in the medical devices industry. Headquartered in Watford, United Kingdom,..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Unlocking a 23.96% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $18.33 billion, the..

Cencora, Inc. (COR) Stock Analysis: Exploring 14.77% Potential Upside and Robust Revenue Growth

Investors eyeing the healthcare sector might find a compelling opportunity in Cencora, Inc. (NYSE: COR), a prominent player in the medical distribution industry. With a market cap of $56.23 billion,..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating the 10.38% Potential Upside for Investors

Investors with an eye on the biotechnology sector should closely consider Exelixis, Inc. (NASDAQ: EXEL), a significant player in the oncology market with a steadfast commitment to pioneering cancer treatments...

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 15% Upside Potential Amidst Analyst Consensus

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, is garnering significant attention from investors seeking opportunities in the medical care facilities industry. With a market..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Potential 11.79% Upside with Strong Buy Ratings

United Therapeutics Corporation (NASDAQ: UTHR) has been capturing investor attention with its robust performance metrics and promising analyst ratings. As a leading biotechnology company, UTHR specializes in addressing critical medical..

Revvity, Inc. (RVTY) Stock Analysis: Discover Its 34.34% Potential Upside

Revvity, Inc. (NYSE: RVTY) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $10.07 billion, this U.S.-based company..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 11.51% Upside Potential

argenx SE (ARGX) is making waves in the biotech industry with a robust pipeline of therapies aimed at tackling some of the most challenging autoimmune diseases. Founded in 2008 and..

Bristol-Myers Squibb (BMY) Stock Analysis: A Closer Look at Its 17.73% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY) continues to attract investor attention with its robust portfolio of biopharmaceutical products and a potential upside of 17.73% based on current analyst ratings. The company,..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with 15.38% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector, particularly within the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure to cutting-edge analytical technology..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 10% Potential Upside Amidst Robust Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector with a market capitalization of $95.02 billion. As a leading provider of health solutions in the..

GSK plc (GSK) Stock Analysis: Insights into a Healthcare Giant with a 4.05% Dividend Yield

GSK plc (GSK), a stalwart in the healthcare sector, operates at the forefront of drug manufacturing, focusing on vaccines, specialty medicines, and general medicines. Headquartered in London, this British multinational..

Genmab A/S (GMAB) Stock Analysis: Exploring Strong Growth Potential with an 18.70% Revenue Surge

For investors seeking opportunities in the booming biotechnology sector, Genmab A/S (NASDAQ: GMAB) presents a compelling case, distinguished by its robust 18.70% revenue growth rate. Based in Copenhagen, Denmark, Genmab..

Agilent Technologies, Inc. (A) Stock Analysis: 10% Upside Potential with Robust Revenue Growth

Agilent Technologies, Inc. (NYSE: A) is a significant player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Santa Clara, California, Agilent has carved a niche..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a Challenging Landscape with Growth Potential

Illumina, Inc. (NASDAQ: ILMN) stands as a prominent player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $15.79 billion, the San Diego-based..

Natera, Inc. (NTRA) Stock Analysis: A Look at the Diagnostics Leader’s Growth Potential and Analyst Confidence

Natera, Inc. (NASDAQ: NTRA) is carving out a formidable presence in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $24.86 billion, the company..

Search

Funds

September 22, 2025

Search

Funds

September 22, 2025

FTSE 100

Funds